Capitolis Liquid Global Markets’s DexCom DXCM Stock Holding History

Capitolis Liquid Global Markets’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-208,000	Closed	-$13.8M	–	350
2025 Q4	$13.8M	Buy	208,000 +33,000	+19%	+$2.13M	0.08%	132
2025 Q3	$11.8M	Hold	175,000	–	–	0.09%	127
2025 Q2	$15.3M	Hold	175,000	–	–	0.11%	122
2025 Q1	$12M	Hold	175,000	–	–	0.11%	110
2024 Q4	$13.6M	Buy	+175,000	New	+$13M	0.13%	74

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capitolis Liquid Global Markets's DXCM Position: Q1 2026 in Review

Capitolis Liquid Global Markets sold out of DexCom (DXCM) in Q1 2026, closing a stake of 208,000 shares — an estimated $13.8M sold.

Capitolis Liquid Global Markets first reported a position in DXCM in Q4 2024 and held it in 5 quarters. The position peaked at $15.3M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Capitolis Liquid Global Markets reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Capitolis Liquid Global Markets sold 208,000 DexCom shares in Q1 2026, an estimated $13.8M.
Capitolis Liquid Global Markets first reported a position in DexCom in Q4 2024 and held it in 5 quarters.
Capitolis Liquid Global Markets's DexCom position peaked at $15.3M in Q2 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2026, filed 15 May 2026.